SPONSOR
CHU de Quebec-Universite Laval
Total Trials
4
Recruiting
4
Phases
N/A
Conditions studied: OsteoporosisMajor Neurocognitive DisorderBreast Cancer Susceptibility Gene (BRCA1) MutationBRCA2 MutationFear of Cancer RecurrenceLimbal Stem Cell Deficiency
CHU de Quebec-Universite Laval is a clinical research sponsor with 4 registered studies on ClinicalTrials.gov, of which 4 are actively recruiting participants. Research covers conditions including Osteoporosis, Major Neurocognitive Disorder, Breast Cancer Susceptibility Gene (BRCA1) Mutation, BRCA2 Mutation.
Studies span multiple clinical phases, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — CHU de Quebec-Universite Laval
How many clinical trials has CHU de Quebec-Universite Laval sponsored?
ClinicalMetric currently tracks 4 clinical trials sponsored by CHU de Quebec-Universite Laval, of which 4 are actively recruiting participants. These trials cover conditions including Osteoporosis, Major Neurocognitive Disorder, Breast Cancer Susceptibility Gene (BRCA1) Mutation. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does CHU de Quebec-Universite Laval research focus on?
CHU de Quebec-Universite Laval clinical trials span Osteoporosis, Major Neurocognitive Disorder, Breast Cancer Susceptibility Gene (BRCA1) Mutation, BRCA2 Mutation, Fear of Cancer Recurrence, and additional conditions. Sponsor focus areas evolve as trials complete and new programs launch.
How do I participate in a CHU de Quebec-Universite Laval clinical trial?
To participate in a CHU de Quebec-Universite Laval trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all CHU de Quebec-Universite Laval trials with current recruitment status updated daily.
Clinical Trials by CHU de Quebec-Universite Laval
NCT07067827
Recruiting
Self-questionnaire in Osteoporosis
Osteoporosis
NCT04889794
Recruiting
GPS Project Evaluation of the Impact of the Reorganization of Work Into a Family Medicine Group on Pharmacotherapy and Support for the Autonomy of Seniors With Major Neurocognitive Disorders
Major Neurocognitive Disorder
NCT06817694
Recruiting
Cognitive Behavioral Therapy for Fear of Cancer Recurrence in Women With BRCA1/2 Gene
Breast Cancer Susceptibility Gene (BRCA1) Mutation
NCT01756365
Recruiting
Autologous Cultured Corneal Epithelium (CECA) for the Treatment of Limbal Stem Cell Deficiency
Limbal Stem Cell Deficiency
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: November 2026 · Data Methodology